Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Efaproxyn and Revaproxyn, new trade names for efaproxiral

June 18, 2004

OSI and Genentech sign new Tarceva agreements

June 18, 2004

Clinical efficacy of a BAY-43-9006 combination regimen in advanced melanoma

June 18, 2004

First phase IIa patients receive BrachySil for liver cancer

June 17, 2004

Symadex enters phase I in patients with advanced solid tumors

June 17, 2004

First patient enrolled in phase I/II study of TheraCIM hR3 for pediatric glioma

June 17, 2004

ZYC-101a shows 100% efficacy in patients with high-grade cervical dysplasia

June 17, 2004

Antitumor effects and safety of rhLF in advanced cancer patients

June 17, 2004

Novogen patent discloses isoflavonoid-based antiproliferative agents

June 16, 2004

New antitumor agents developed by Sanofi-Synthelabo scientists

June 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...